Strata Critical Medical, Inc.
General ticker "SRTA" information:
- Sector: Industrials
- Industry: Airlines, Airports & Air Services
- Capitalization: $390.3M (TTM average)
Strata Critical Medical, Inc. follows the US Stock Market performance with the rate: 60.3%.
Estimated limits based on current volatility of 3.6%: low 5.56$, high 5.97$
Factors to consider:
- Total employees count: 3 as of 2019
- US accounted for 88.0% of revenue in the fiscal year ended 2024-12-31
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.97$, 6.59$]
- 2026-12-31 to 2027-12-31 estimated range: [3.89$, 6.56$]
Financial Metrics affecting the SRTA estimates:
- Positive: with PPE of -23.6 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 16.88 > -0.60
- Negative: negative Net income
- Positive: Shareholder equity ratio, % of 85.74 > 64.29
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term SRTA quotes
Long-term SRTA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $225.18MM | $248.69MM | $197.14MM |
| Operating Expenses | $293.30MM | $282.62MM | $219.49MM |
| Operating Income | $-68.12MM | $-33.93MM | $-22.35MM |
| Non-Operating Income | $10.57MM | $6.36MM | $2.29MM |
| R&D Expense | $4.63MM | $3.18MM | $0.00MM |
| Income(Loss) | $-57.54MM | $-27.56MM | $-20.07MM |
| Taxes | $-1.47MM | $-0.26MM | $0.00MM |
| Other Income(Loss) | $0.00MM | $0.00MM | $61.41MM |
| Net Income(Loss)* | $-56.08MM | $-27.31MM | $41.35MM |
| Stockholders Equity | $234.30MM | $221.94MM | $279.07MM |
| Assets | $294.94MM | $256.68MM | $325.47MM |
| Operating Cash Flow | $-32.35MM | $-2.52MM | $-48.91MM |
| Capital expenditure | $2.11MM | $32.99MM | $11.01MM |
| Investing Cash Flow | $17.09MM | $-1.02MM | $69.75MM |
| Financing Cash Flow | $-0.08MM | $-5.76MM | $-8.91MM |
| Earnings Per Share** | $-0.76 | $-0.35 | $0.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.